181 related articles for article (PubMed ID: 37438143)
1. Exploration of New Therapies for Heart Failure Targeting Age-Related Mechanisms.
Shimizu I
Circ J; 2024 Apr; 88(5):626-630. PubMed ID: 37438143
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in cardiac diseases.
Shimizu I; Minamino T
J Cardiol; 2019 Oct; 74(4):313-319. PubMed ID: 31202488
[TBL] [Abstract][Full Text] [Related]
3. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
Boccardi V; Mecocci P
Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
[TBL] [Abstract][Full Text] [Related]
4. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
5. Vascular Senescence in Cardiovascular and Metabolic Diseases.
Katsuumi G; Shimizu I; Yoshida Y; Minamino T
Front Cardiovasc Med; 2018; 5():18. PubMed ID: 29556500
[TBL] [Abstract][Full Text] [Related]
6. Targeting cellular senescence in metabolic disease.
Palmer AK; Tchkonia T; Kirkland JL
Mol Metab; 2022 Dec; 66():101601. PubMed ID: 36116755
[TBL] [Abstract][Full Text] [Related]
7. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.
Suda M; Shimizu I; Katsuumi G; Yoshida Y; Hayashi Y; Ikegami R; Matsumoto N; Yoshida Y; Mikawa R; Katayama A; Wada J; Seki M; Suzuki Y; Iwama A; Nakagami H; Nagasawa A; Morishita R; Sugimoto M; Okuda S; Tsuchida M; Ozaki K; Nakanishi-Matsui M; Minamino T
Nat Aging; 2021 Dec; 1(12):1117-1126. PubMed ID: 37117524
[TBL] [Abstract][Full Text] [Related]
8. Capillaries as a Therapeutic Target for Heart Failure.
Yoshida Y; Shimizu I; Minamino T
J Atheroscler Thromb; 2022 Jul; 29(7):971-988. PubMed ID: 35370224
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic opportunities for senolysis in cardiovascular disease.
Sweeney M; Cook SA; Gil J
FEBS J; 2023 Mar; 290(5):1235-1255. PubMed ID: 35015342
[TBL] [Abstract][Full Text] [Related]
10. Local senolysis in aged mice only partially replicates the benefits of systemic senolysis.
Farr JN; Saul D; Doolittle ML; Kaur J; Rowsey JL; Vos SJ; Froemming MN; Lagnado AB; Zhu Y; Weivoda M; Ikeno Y; Pignolo RJ; Niedernhofer LJ; Robbins PD; Jurk D; Passos JF; LeBrasseur NK; Tchkonia T; Kirkland JL; Monroe DG; Khosla S
J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36809340
[TBL] [Abstract][Full Text] [Related]
11. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
12. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
[TBL] [Abstract][Full Text] [Related]
13. Cellular senescence and its role in white adipose tissue.
Smith U; Li Q; Rydén M; Spalding KL
Int J Obes (Lond); 2021 May; 45(5):934-943. PubMed ID: 33510393
[TBL] [Abstract][Full Text] [Related]
14. Cellular Senescence in Arterial Diseases.
Shimizu I; Minamino T
J Lipid Atheroscler; 2020 Jan; 9(1):79-91. PubMed ID: 32821723
[TBL] [Abstract][Full Text] [Related]
15. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
16. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
18. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis resistance of senescent cells is an intrinsic barrier for senolysis induced by cardiac glycosides.
Deryabin PI; Shatrova AN; Borodkina AV
Cell Mol Life Sci; 2021 Dec; 78(23):7757-7776. PubMed ID: 34714358
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases.
Lee HJ; Yoon YS; Lee SJ
J Mol Biol; 2023 Jun; 435(12):168114. PubMed ID: 37085010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
